nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—CYP2C8—Raloxifene—osteoporosis	0.0805	0.121	CbGbCtD
Sitagliptin—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0777	0.117	CbGbCtD
Sitagliptin—CYP2C8—Cholecalciferol—osteoporosis	0.0621	0.0934	CbGbCtD
Sitagliptin—ABCB1—Ethinyl Estradiol—osteoporosis	0.0526	0.0791	CbGbCtD
Sitagliptin—CYP2C8—Estradiol—osteoporosis	0.0501	0.0753	CbGbCtD
Sitagliptin—CYP3A4—Estropipate—osteoporosis	0.0489	0.0735	CbGbCtD
Sitagliptin—CYP3A4—Calcitriol—osteoporosis	0.0489	0.0735	CbGbCtD
Sitagliptin—CYP3A4—Ergocalciferol—osteoporosis	0.0391	0.0588	CbGbCtD
Sitagliptin—ABCB1—Conjugated Estrogens—osteoporosis	0.0386	0.058	CbGbCtD
Sitagliptin—ABCB1—Estradiol—osteoporosis	0.0339	0.051	CbGbCtD
Sitagliptin—CYP3A4—Raloxifene—osteoporosis	0.0326	0.0491	CbGbCtD
Sitagliptin—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0315	0.0474	CbGbCtD
Sitagliptin—CYP3A4—Cholecalciferol—osteoporosis	0.0252	0.0379	CbGbCtD
Sitagliptin—CYP3A4—Conjugated Estrogens—osteoporosis	0.0231	0.0348	CbGbCtD
Sitagliptin—CYP3A4—Estradiol—osteoporosis	0.0203	0.0305	CbGbCtD
Sitagliptin—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000438	0.114	CbGpPWpGaD
Sitagliptin—Arthralgia—Pamidronate—osteoporosis	0.000327	0.000989	CcSEcCtD
Sitagliptin—Back pain—Conjugated Estrogens—osteoporosis	0.000327	0.000988	CcSEcCtD
Sitagliptin—Urticaria—Alendronate—osteoporosis	0.000327	0.000987	CcSEcCtD
Sitagliptin—Anxiety—Pamidronate—osteoporosis	0.000326	0.000985	CcSEcCtD
Sitagliptin—Ill-defined disorder—Zoledronate—osteoporosis	0.000326	0.000984	CcSEcCtD
Sitagliptin—Abdominal pain—Alendronate—osteoporosis	0.000325	0.000982	CcSEcCtD
Sitagliptin—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000325	0.000982	CcSEcCtD
Sitagliptin—Sinusitis—Estradiol—osteoporosis	0.000325	0.000982	CcSEcCtD
Sitagliptin—Nervous system disorder—Risedronate—osteoporosis	0.000324	0.000978	CcSEcCtD
Sitagliptin—Discomfort—Pamidronate—osteoporosis	0.000323	0.000977	CcSEcCtD
Sitagliptin—Angioedema—Zoledronate—osteoporosis	0.000321	0.000969	CcSEcCtD
Sitagliptin—Skin disorder—Risedronate—osteoporosis	0.00032	0.000969	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Calcitriol—osteoporosis	0.00032	0.000969	CcSEcCtD
Sitagliptin—Abdominal pain—Raloxifene—osteoporosis	0.00032	0.000966	CcSEcCtD
Sitagliptin—Vision blurred—Conjugated Estrogens—osteoporosis	0.000319	0.000963	CcSEcCtD
Sitagliptin—Urticaria—Ibandronate—osteoporosis	0.000318	0.000961	CcSEcCtD
Sitagliptin—Malaise—Zoledronate—osteoporosis	0.000317	0.000957	CcSEcCtD
Sitagliptin—Abdominal pain—Ibandronate—osteoporosis	0.000317	0.000957	CcSEcCtD
Sitagliptin—Vertigo—Zoledronate—osteoporosis	0.000315	0.000953	CcSEcCtD
Sitagliptin—Anaphylactic shock—Pamidronate—osteoporosis	0.000314	0.000948	CcSEcCtD
Sitagliptin—Infection—Pamidronate—osteoporosis	0.000312	0.000942	CcSEcCtD
Sitagliptin—Urticaria—Calcitriol—osteoporosis	0.000311	0.000941	CcSEcCtD
Sitagliptin—Abdominal pain—Calcitriol—osteoporosis	0.00031	0.000936	CcSEcCtD
Sitagliptin—Hypoaesthesia—Estradiol—osteoporosis	0.000309	0.000935	CcSEcCtD
Sitagliptin—Angioedema—Conjugated Estrogens—osteoporosis	0.000309	0.000933	CcSEcCtD
Sitagliptin—Pharyngitis—Estradiol—osteoporosis	0.000308	0.000932	CcSEcCtD
Sitagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—LEP—osteoporosis	0.000308	0.0798	CbGpPWpGaD
Sitagliptin—Hypersensitivity—Estropipate—osteoporosis	0.000308	0.00093	CcSEcCtD
Sitagliptin—Nervous system disorder—Pamidronate—osteoporosis	0.000308	0.00093	CcSEcCtD
Sitagliptin—Urinary tract disorder—Estradiol—osteoporosis	0.000307	0.000928	CcSEcCtD
Sitagliptin—Vomiting—Etidronic acid—osteoporosis	0.000307	0.000927	CcSEcCtD
Sitagliptin—Cough—Zoledronate—osteoporosis	0.000306	0.000926	CcSEcCtD
Sitagliptin—Oedema peripheral—Estradiol—osteoporosis	0.000306	0.000925	CcSEcCtD
Sitagliptin—Connective tissue disorder—Estradiol—osteoporosis	0.000305	0.000923	CcSEcCtD
Sitagliptin—Urethral disorder—Estradiol—osteoporosis	0.000305	0.000921	CcSEcCtD
Sitagliptin—Rash—Etidronic acid—osteoporosis	0.000304	0.00092	CcSEcCtD
Sitagliptin—Dermatitis—Etidronic acid—osteoporosis	0.000304	0.000919	CcSEcCtD
Sitagliptin—Vertigo—Conjugated Estrogens—osteoporosis	0.000304	0.000918	CcSEcCtD
Sitagliptin—Hypertension—Zoledronate—osteoporosis	0.000303	0.000916	CcSEcCtD
Sitagliptin—Hypersensitivity—Alendronate—osteoporosis	0.000303	0.000916	CcSEcCtD
Sitagliptin—Headache—Etidronic acid—osteoporosis	0.000302	0.000914	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000301	0.000909	CcSEcCtD
Sitagliptin—Asthenia—Estropipate—osteoporosis	0.0003	0.000905	CcSEcCtD
Sitagliptin—Myalgia—Zoledronate—osteoporosis	0.000299	0.000903	CcSEcCtD
Sitagliptin—Arthralgia—Zoledronate—osteoporosis	0.000299	0.000903	CcSEcCtD
Sitagliptin—Insomnia—Risedronate—osteoporosis	0.000298	0.000902	CcSEcCtD
Sitagliptin—Anxiety—Zoledronate—osteoporosis	0.000298	0.0009	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000297	0.000897	CcSEcCtD
Sitagliptin—Discomfort—Zoledronate—osteoporosis	0.000295	0.000892	CcSEcCtD
Sitagliptin—Asthenia—Alendronate—osteoporosis	0.000295	0.000892	CcSEcCtD
Sitagliptin—Hypersensitivity—Ibandronate—osteoporosis	0.000295	0.000891	CcSEcCtD
Sitagliptin—Cough—Conjugated Estrogens—osteoporosis	0.000295	0.000891	CcSEcCtD
Sitagliptin—Erythema multiforme—Estradiol—osteoporosis	0.000294	0.000888	CcSEcCtD
Sitagliptin—Dry mouth—Zoledronate—osteoporosis	0.000292	0.000883	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000292	0.000883	CcSEcCtD
Sitagliptin—Fatigue—Ethinyl Estradiol—osteoporosis	0.000292	0.000882	CcSEcCtD
Sitagliptin—Dyspepsia—Risedronate—osteoporosis	0.00029	0.000878	CcSEcCtD
Sitagliptin—Eye disorder—Estradiol—osteoporosis	0.00029	0.000878	CcSEcCtD
Sitagliptin—Constipation—Ethinyl Estradiol—osteoporosis	0.000289	0.000875	CcSEcCtD
Sitagliptin—Hypersensitivity—Calcitriol—osteoporosis	0.000289	0.000873	CcSEcCtD
Sitagliptin—Cardiac disorder—Estradiol—osteoporosis	0.000288	0.000872	CcSEcCtD
Sitagliptin—Myalgia—Conjugated Estrogens—osteoporosis	0.000288	0.00087	CcSEcCtD
Sitagliptin—Arthralgia—Conjugated Estrogens—osteoporosis	0.000288	0.00087	CcSEcCtD
Sitagliptin—Asthenia—Ibandronate—osteoporosis	0.000287	0.000868	CcSEcCtD
Sitagliptin—Anxiety—Conjugated Estrogens—osteoporosis	0.000287	0.000867	CcSEcCtD
Sitagliptin—Nausea—Etidronic acid—osteoporosis	0.000287	0.000866	CcSEcCtD
Sitagliptin—Anaphylactic shock—Zoledronate—osteoporosis	0.000287	0.000866	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000286	0.000864	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000286	0.000864	CcSEcCtD
Sitagliptin—Diarrhoea—Estropipate—osteoporosis	0.000286	0.000863	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Risedronate—osteoporosis	0.000285	0.000861	CcSEcCtD
Sitagliptin—Infection—Zoledronate—osteoporosis	0.000285	0.00086	CcSEcCtD
Sitagliptin—Fatigue—Risedronate—osteoporosis	0.000284	0.00086	CcSEcCtD
Sitagliptin—Insomnia—Pamidronate—osteoporosis	0.000284	0.000857	CcSEcCtD
Sitagliptin—Pain—Risedronate—osteoporosis	0.000282	0.000853	CcSEcCtD
Sitagliptin—Constipation—Risedronate—osteoporosis	0.000282	0.000853	CcSEcCtD
Sitagliptin—Angiopathy—Estradiol—osteoporosis	0.000282	0.000852	CcSEcCtD
Sitagliptin—Diarrhoea—Alendronate—osteoporosis	0.000281	0.00085	CcSEcCtD
Sitagliptin—Asthenia—Calcitriol—osteoporosis	0.000281	0.00085	CcSEcCtD
Sitagliptin—Nervous system disorder—Zoledronate—osteoporosis	0.000281	0.000849	CcSEcCtD
Sitagliptin—Immune system disorder—Estradiol—osteoporosis	0.000281	0.000848	CcSEcCtD
Sitagliptin—Mediastinal disorder—Estradiol—osteoporosis	0.00028	0.000846	CcSEcCtD
Sitagliptin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000279	0.000843	CcSEcCtD
Sitagliptin—Somnolence—Pamidronate—osteoporosis	0.000279	0.000843	CcSEcCtD
Sitagliptin—Skin disorder—Zoledronate—osteoporosis	0.000278	0.000841	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000277	0.000836	CcSEcCtD
Sitagliptin—Diarrhoea—Raloxifene—osteoporosis	0.000277	0.000836	CcSEcCtD
Sitagliptin—Dyspepsia—Pamidronate—osteoporosis	0.000276	0.000834	CcSEcCtD
Sitagliptin—Dizziness—Estropipate—osteoporosis	0.000276	0.000834	CcSEcCtD
Sitagliptin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000276	0.000834	CcSEcCtD
Sitagliptin—Infection—Conjugated Estrogens—osteoporosis	0.000274	0.000828	CcSEcCtD
Sitagliptin—Diarrhoea—Ibandronate—osteoporosis	0.000274	0.000828	CcSEcCtD
Sitagliptin—DPP4—Incretin synthesis, secretion, and inactivation—LEP—osteoporosis	0.000274	0.071	CbGpPWpGaD
Sitagliptin—Decreased appetite—Pamidronate—osteoporosis	0.000273	0.000824	CcSEcCtD
Sitagliptin—Mental disorder—Estradiol—osteoporosis	0.000272	0.000823	CcSEcCtD
Sitagliptin—Dizziness—Alendronate—osteoporosis	0.000272	0.000822	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000271	0.000818	CcSEcCtD
Sitagliptin—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000271	0.000818	CcSEcCtD
Sitagliptin—Malnutrition—Estradiol—osteoporosis	0.000271	0.000818	CcSEcCtD
Sitagliptin—Fatigue—Pamidronate—osteoporosis	0.00027	0.000817	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Risedronate—osteoporosis	0.00027	0.000815	CcSEcCtD
Sitagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00027	0.07	CbGpPWpGaD
Sitagliptin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000269	0.000813	CcSEcCtD
Sitagliptin—Constipation—Pamidronate—osteoporosis	0.000268	0.000811	CcSEcCtD
Sitagliptin—Pain—Pamidronate—osteoporosis	0.000268	0.000811	CcSEcCtD
Sitagliptin—Diarrhoea—Calcitriol—osteoporosis	0.000268	0.00081	CcSEcCtD
Sitagliptin—Skin disorder—Conjugated Estrogens—osteoporosis	0.000268	0.00081	CcSEcCtD
Sitagliptin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000268	0.000809	CcSEcCtD
Sitagliptin—Dizziness—Raloxifene—osteoporosis	0.000267	0.000808	CcSEcCtD
Sitagliptin—Flatulence—Estradiol—osteoporosis	0.000267	0.000806	CcSEcCtD
Sitagliptin—Tension—Estradiol—osteoporosis	0.000265	0.000802	CcSEcCtD
Sitagliptin—Vomiting—Estropipate—osteoporosis	0.000265	0.000802	CcSEcCtD
Sitagliptin—Dizziness—Ibandronate—osteoporosis	0.000265	0.0008	CcSEcCtD
Sitagliptin—Rash—Estropipate—osteoporosis	0.000263	0.000796	CcSEcCtD
Sitagliptin—Dermatitis—Estropipate—osteoporosis	0.000263	0.000795	CcSEcCtD
Sitagliptin—Nervousness—Estradiol—osteoporosis	0.000263	0.000794	CcSEcCtD
Sitagliptin—Urticaria—Risedronate—osteoporosis	0.000262	0.000792	CcSEcCtD
Sitagliptin—Back pain—Estradiol—osteoporosis	0.000262	0.000791	CcSEcCtD
Sitagliptin—Headache—Estropipate—osteoporosis	0.000262	0.00079	CcSEcCtD
Sitagliptin—Vomiting—Alendronate—osteoporosis	0.000261	0.00079	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000261	0.000789	CcSEcCtD
Sitagliptin—Abdominal pain—Risedronate—osteoporosis	0.000261	0.000788	CcSEcCtD
Sitagliptin—Muscle spasms—Estradiol—osteoporosis	0.00026	0.000786	CcSEcCtD
Sitagliptin—Rash—Alendronate—osteoporosis	0.000259	0.000784	CcSEcCtD
Sitagliptin—Insomnia—Zoledronate—osteoporosis	0.000259	0.000783	CcSEcCtD
Sitagliptin—Dermatitis—Alendronate—osteoporosis	0.000259	0.000783	CcSEcCtD
Sitagliptin—Feeling abnormal—Pamidronate—osteoporosis	0.000258	0.000781	CcSEcCtD
Sitagliptin—Headache—Alendronate—osteoporosis	0.000258	0.000779	CcSEcCtD
Sitagliptin—Vomiting—Raloxifene—osteoporosis	0.000257	0.000777	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000256	0.000775	CcSEcCtD
Sitagliptin—Rash—Raloxifene—osteoporosis	0.000255	0.000771	CcSEcCtD
Sitagliptin—Dermatitis—Raloxifene—osteoporosis	0.000255	0.00077	CcSEcCtD
Sitagliptin—Somnolence—Zoledronate—osteoporosis	0.000255	0.00077	CcSEcCtD
Sitagliptin—Vomiting—Ibandronate—osteoporosis	0.000255	0.000769	CcSEcCtD
Sitagliptin—Headache—Raloxifene—osteoporosis	0.000253	0.000766	CcSEcCtD
Sitagliptin—Rash—Ibandronate—osteoporosis	0.000252	0.000763	CcSEcCtD
Sitagliptin—Dermatitis—Ibandronate—osteoporosis	0.000252	0.000762	CcSEcCtD
Sitagliptin—Dyspepsia—Zoledronate—osteoporosis	0.000252	0.000762	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000251	0.00076	CcSEcCtD
Sitagliptin—Ill-defined disorder—Estradiol—osteoporosis	0.000251	0.000759	CcSEcCtD
Sitagliptin—Headache—Ibandronate—osteoporosis	0.000251	0.000758	CcSEcCtD
Sitagliptin—Insomnia—Conjugated Estrogens—osteoporosis	0.00025	0.000754	CcSEcCtD
Sitagliptin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000249	0.000754	CcSEcCtD
Sitagliptin—Vomiting—Calcitriol—osteoporosis	0.000249	0.000753	CcSEcCtD
Sitagliptin—Decreased appetite—Zoledronate—osteoporosis	0.000249	0.000753	CcSEcCtD
Sitagliptin—Nausea—Estropipate—osteoporosis	0.000248	0.00075	CcSEcCtD
Sitagliptin—Abdominal pain—Pamidronate—osteoporosis	0.000248	0.000749	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000247	0.000748	CcSEcCtD
Sitagliptin—Angioedema—Estradiol—osteoporosis	0.000247	0.000747	CcSEcCtD
Sitagliptin—Rash—Calcitriol—osteoporosis	0.000247	0.000747	CcSEcCtD
Sitagliptin—Fatigue—Zoledronate—osteoporosis	0.000247	0.000747	CcSEcCtD
Sitagliptin—Dermatitis—Calcitriol—osteoporosis	0.000247	0.000746	CcSEcCtD
Sitagliptin—Headache—Calcitriol—osteoporosis	0.000246	0.000742	CcSEcCtD
Sitagliptin—Somnolence—Conjugated Estrogens—osteoporosis	0.000245	0.000741	CcSEcCtD
Sitagliptin—Pain—Zoledronate—osteoporosis	0.000245	0.00074	CcSEcCtD
Sitagliptin—Constipation—Zoledronate—osteoporosis	0.000245	0.00074	CcSEcCtD
Sitagliptin—Nausea—Alendronate—osteoporosis	0.000244	0.000738	CcSEcCtD
Sitagliptin—Malaise—Estradiol—osteoporosis	0.000244	0.000737	CcSEcCtD
Sitagliptin—Hypersensitivity—Risedronate—osteoporosis	0.000243	0.000735	CcSEcCtD
Sitagliptin—Vertigo—Estradiol—osteoporosis	0.000243	0.000735	CcSEcCtD
Sitagliptin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000243	0.000734	CcSEcCtD
Sitagliptin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000243	0.000734	CcSEcCtD
Sitagliptin—Nausea—Raloxifene—osteoporosis	0.00024	0.000726	CcSEcCtD
Sitagliptin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00024	0.000725	CcSEcCtD
Sitagliptin—DPP4—Peptide hormone metabolism—REN—osteoporosis	0.000239	0.0621	CbGpPWpGaD
Sitagliptin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000238	0.00072	CcSEcCtD
Sitagliptin—Fatigue—Conjugated Estrogens—osteoporosis	0.000238	0.000719	CcSEcCtD
Sitagliptin—Nausea—Ibandronate—osteoporosis	0.000238	0.000719	CcSEcCtD
Sitagliptin—Asthenia—Risedronate—osteoporosis	0.000237	0.000715	CcSEcCtD
Sitagliptin—Feeling abnormal—Zoledronate—osteoporosis	0.000236	0.000714	CcSEcCtD
Sitagliptin—Cough—Estradiol—osteoporosis	0.000236	0.000713	CcSEcCtD
Sitagliptin—Pain—Conjugated Estrogens—osteoporosis	0.000236	0.000713	CcSEcCtD
Sitagliptin—Constipation—Conjugated Estrogens—osteoporosis	0.000236	0.000713	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000234	0.000708	CcSEcCtD
Sitagliptin—Hypertension—Estradiol—osteoporosis	0.000234	0.000706	CcSEcCtD
Sitagliptin—Nausea—Calcitriol—osteoporosis	0.000233	0.000704	CcSEcCtD
Sitagliptin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000232	0.0007	CcSEcCtD
Sitagliptin—Hypersensitivity—Pamidronate—osteoporosis	0.000231	0.000698	CcSEcCtD
Sitagliptin—Myalgia—Estradiol—osteoporosis	0.00023	0.000696	CcSEcCtD
Sitagliptin—Arthralgia—Estradiol—osteoporosis	0.00023	0.000696	CcSEcCtD
Sitagliptin—Anxiety—Estradiol—osteoporosis	0.00023	0.000694	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000229	0.000691	CcSEcCtD
Sitagliptin—Urticaria—Zoledronate—osteoporosis	0.000228	0.000688	CcSEcCtD
Sitagliptin—Discomfort—Estradiol—osteoporosis	0.000228	0.000688	CcSEcCtD
Sitagliptin—Abdominal pain—Zoledronate—osteoporosis	0.000226	0.000685	CcSEcCtD
Sitagliptin—Diarrhoea—Risedronate—osteoporosis	0.000226	0.000682	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000226	0.000682	CcSEcCtD
Sitagliptin—Dry mouth—Estradiol—osteoporosis	0.000225	0.000681	CcSEcCtD
Sitagliptin—Asthenia—Pamidronate—osteoporosis	0.000225	0.00068	CcSEcCtD
Sitagliptin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000224	0.000676	CcSEcCtD
Sitagliptin—Anaphylactic shock—Estradiol—osteoporosis	0.000221	0.000667	CcSEcCtD
Sitagliptin—Infection—Estradiol—osteoporosis	0.000219	0.000663	CcSEcCtD
Sitagliptin—Urticaria—Conjugated Estrogens—osteoporosis	0.000219	0.000662	CcSEcCtD
Sitagliptin—Dizziness—Risedronate—osteoporosis	0.000218	0.000659	CcSEcCtD
Sitagliptin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000218	0.000659	CcSEcCtD
Sitagliptin—Nervous system disorder—Estradiol—osteoporosis	0.000217	0.000654	CcSEcCtD
Sitagliptin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000215	0.00065	CcSEcCtD
Sitagliptin—Diarrhoea—Pamidronate—osteoporosis	0.000215	0.000649	CcSEcCtD
Sitagliptin—Skin disorder—Estradiol—osteoporosis	0.000214	0.000648	CcSEcCtD
Sitagliptin—Rash—Ethinyl Estradiol—osteoporosis	0.000213	0.000645	CcSEcCtD
Sitagliptin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000213	0.000644	CcSEcCtD
Sitagliptin—Headache—Ethinyl Estradiol—osteoporosis	0.000212	0.000641	CcSEcCtD
Sitagliptin—Hypersensitivity—Zoledronate—osteoporosis	0.000211	0.000638	CcSEcCtD
Sitagliptin—Vomiting—Risedronate—osteoporosis	0.00021	0.000634	CcSEcCtD
Sitagliptin—Rash—Risedronate—osteoporosis	0.000208	0.000629	CcSEcCtD
Sitagliptin—Dermatitis—Risedronate—osteoporosis	0.000208	0.000628	CcSEcCtD
Sitagliptin—Dizziness—Pamidronate—osteoporosis	0.000207	0.000627	CcSEcCtD
Sitagliptin—Headache—Risedronate—osteoporosis	0.000207	0.000625	CcSEcCtD
Sitagliptin—Asthenia—Zoledronate—osteoporosis	0.000206	0.000621	CcSEcCtD
Sitagliptin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000203	0.000614	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000201	0.000608	CcSEcCtD
Sitagliptin—Nausea—Ethinyl Estradiol—osteoporosis	0.000201	0.000608	CcSEcCtD
Sitagliptin—Insomnia—Estradiol—osteoporosis	0.0002	0.000604	CcSEcCtD
Sitagliptin—Vomiting—Pamidronate—osteoporosis	0.000199	0.000603	CcSEcCtD
Sitagliptin—Asthenia—Conjugated Estrogens—osteoporosis	0.000198	0.000598	CcSEcCtD
Sitagliptin—Rash—Pamidronate—osteoporosis	0.000198	0.000598	CcSEcCtD
Sitagliptin—Dermatitis—Pamidronate—osteoporosis	0.000198	0.000597	CcSEcCtD
Sitagliptin—Headache—Pamidronate—osteoporosis	0.000196	0.000594	CcSEcCtD
Sitagliptin—Somnolence—Estradiol—osteoporosis	0.000196	0.000593	CcSEcCtD
Sitagliptin—Diarrhoea—Zoledronate—osteoporosis	0.000196	0.000592	CcSEcCtD
Sitagliptin—Nausea—Risedronate—osteoporosis	0.000196	0.000592	CcSEcCtD
Sitagliptin—Dyspepsia—Estradiol—osteoporosis	0.000194	0.000587	CcSEcCtD
Sitagliptin—Decreased appetite—Estradiol—osteoporosis	0.000192	0.00058	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Estradiol—osteoporosis	0.000191	0.000576	CcSEcCtD
Sitagliptin—Fatigue—Estradiol—osteoporosis	0.00019	0.000575	CcSEcCtD
Sitagliptin—Dizziness—Zoledronate—osteoporosis	0.000189	0.000573	CcSEcCtD
Sitagliptin—Constipation—Estradiol—osteoporosis	0.000189	0.000571	CcSEcCtD
Sitagliptin—Pain—Estradiol—osteoporosis	0.000189	0.000571	CcSEcCtD
Sitagliptin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000189	0.00057	CcSEcCtD
Sitagliptin—Nausea—Pamidronate—osteoporosis	0.000186	0.000563	CcSEcCtD
Sitagliptin—Dizziness—Conjugated Estrogens—osteoporosis	0.000182	0.000551	CcSEcCtD
Sitagliptin—Vomiting—Zoledronate—osteoporosis	0.000182	0.000551	CcSEcCtD
Sitagliptin—Feeling abnormal—Estradiol—osteoporosis	0.000182	0.00055	CcSEcCtD
Sitagliptin—Rash—Zoledronate—osteoporosis	0.000181	0.000546	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Estradiol—osteoporosis	0.000181	0.000546	CcSEcCtD
Sitagliptin—Dermatitis—Zoledronate—osteoporosis	0.00018	0.000545	CcSEcCtD
Sitagliptin—Headache—Zoledronate—osteoporosis	0.000179	0.000542	CcSEcCtD
Sitagliptin—Vomiting—Conjugated Estrogens—osteoporosis	0.000175	0.00053	CcSEcCtD
Sitagliptin—Urticaria—Estradiol—osteoporosis	0.000175	0.00053	CcSEcCtD
Sitagliptin—Abdominal pain—Estradiol—osteoporosis	0.000175	0.000528	CcSEcCtD
Sitagliptin—Rash—Conjugated Estrogens—osteoporosis	0.000174	0.000526	CcSEcCtD
Sitagliptin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000174	0.000525	CcSEcCtD
Sitagliptin—Headache—Conjugated Estrogens—osteoporosis	0.000173	0.000522	CcSEcCtD
Sitagliptin—Nausea—Zoledronate—osteoporosis	0.00017	0.000514	CcSEcCtD
Sitagliptin—Nausea—Conjugated Estrogens—osteoporosis	0.000164	0.000495	CcSEcCtD
Sitagliptin—Hypersensitivity—Estradiol—osteoporosis	0.000163	0.000492	CcSEcCtD
Sitagliptin—Asthenia—Estradiol—osteoporosis	0.000158	0.000479	CcSEcCtD
Sitagliptin—Diarrhoea—Estradiol—osteoporosis	0.000151	0.000457	CcSEcCtD
Sitagliptin—DPP4—Peptide hormone metabolism—ACE—osteoporosis	0.000149	0.0388	CbGpPWpGaD
Sitagliptin—Dizziness—Estradiol—osteoporosis	0.000146	0.000441	CcSEcCtD
Sitagliptin—Vomiting—Estradiol—osteoporosis	0.00014	0.000424	CcSEcCtD
Sitagliptin—Rash—Estradiol—osteoporosis	0.000139	0.000421	CcSEcCtD
Sitagliptin—Dermatitis—Estradiol—osteoporosis	0.000139	0.00042	CcSEcCtD
Sitagliptin—Headache—Estradiol—osteoporosis	0.000138	0.000418	CcSEcCtD
Sitagliptin—Nausea—Estradiol—osteoporosis	0.000131	0.000396	CcSEcCtD
Sitagliptin—DPP4—Peptide hormone metabolism—LEP—osteoporosis	9.28e-05	0.0241	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—PKM—osteoporosis	8.96e-05	0.0233	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—POMC—osteoporosis	7.97e-05	0.0207	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—CCT2—osteoporosis	7.87e-05	0.0204	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—IGF1—osteoporosis	7.67e-05	0.0199	CbGpPWpGaD
Sitagliptin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	7e-05	0.0182	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—TUBA1B—osteoporosis	6.69e-05	0.0174	CbGpPWpGaD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	6.38e-05	0.0165	CbGpPWpGaD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	6.29e-05	0.0163	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—TUBA1B—osteoporosis	6.26e-05	0.0162	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—RPL24—osteoporosis	5.35e-05	0.0139	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	5.17e-05	0.0134	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—TLN1—osteoporosis	4.7e-05	0.0122	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—REN—osteoporosis	4.52e-05	0.0117	CbGpPWpGaD
Sitagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	4.31e-05	0.0112	CbGpPWpGaD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	4.02e-05	0.0104	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	3.42e-05	0.00888	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	3.38e-05	0.00878	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	3.38e-05	0.00876	CbGpPWpGaD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	3.35e-05	0.00869	CbGpPWpGaD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	3.31e-05	0.00858	CbGpPWpGaD
Sitagliptin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	3.22e-05	0.00837	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—GPX1—osteoporosis	3.16e-05	0.00819	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—ACE—osteoporosis	2.82e-05	0.00732	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	2.77e-05	0.0072	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP27A1—osteoporosis	2.75e-05	0.00712	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	2.72e-05	0.00705	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP27A1—osteoporosis	2.71e-05	0.00703	CbGpPWpGaD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	2.48e-05	0.00642	CbGpPWpGaD
Sitagliptin—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	2.22e-05	0.00577	CbGpPWpGaD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.01e-05	0.00522	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	1.89e-05	0.00491	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	1.84e-05	0.00476	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	1.8e-05	0.00467	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	1.79e-05	0.00464	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	1.77e-05	0.0046	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—LEP—osteoporosis	1.75e-05	0.00455	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	1.74e-05	0.00452	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.63e-05	0.00423	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—POMC—osteoporosis	1.5e-05	0.00391	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	1.47e-05	0.00382	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.46e-05	0.00378	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	1.45e-05	0.00377	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—IGF1—osteoporosis	1.45e-05	0.00376	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP19A1—osteoporosis	1.44e-05	0.00374	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP19A1—osteoporosis	1.42e-05	0.00369	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.35e-05	0.00351	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.32e-05	0.00342	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	1.27e-05	0.0033	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	1.19e-05	0.00309	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.08e-05	0.0028	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.05e-05	0.00274	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IL1B—osteoporosis	1.04e-05	0.00271	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	9.99e-06	0.00259	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	8.96e-06	0.00233	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.76e-06	0.00227	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—POMC—osteoporosis	8.67e-06	0.00225	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PKM—osteoporosis	8.18e-06	0.00212	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—FDPS—osteoporosis	8.18e-06	0.00212	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—TGFB1—osteoporosis	8.11e-06	0.00211	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PGLS—osteoporosis	7.75e-06	0.00201	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GPD2—osteoporosis	7.75e-06	0.00201	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	7.74e-06	0.00201	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	7.72e-06	0.002	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	7.64e-06	0.00198	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—TNF—osteoporosis	7.58e-06	0.00197	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PKM—osteoporosis	7.12e-06	0.00185	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—FDPS—osteoporosis	7.12e-06	0.00185	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ATIC—osteoporosis	7.09e-06	0.00184	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PNP—osteoporosis	7.09e-06	0.00184	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PGLS—osteoporosis	6.75e-06	0.00175	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GPD2—osteoporosis	6.75e-06	0.00175	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	6.68e-06	0.00173	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ATIC—osteoporosis	6.18e-06	0.0016	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PNP—osteoporosis	6.18e-06	0.0016	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—OXCT1—osteoporosis	6.03e-06	0.00156	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CA2—osteoporosis	6.03e-06	0.00156	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—MGLL—osteoporosis	5.87e-06	0.00152	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.54e-06	0.00144	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—OXCT1—osteoporosis	5.25e-06	0.00136	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CA2—osteoporosis	5.25e-06	0.00136	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—MGLL—osteoporosis	5.12e-06	0.00133	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—IDH2—osteoporosis	4.99e-06	0.0013	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP27A1—osteoporosis	4.7e-06	0.00122	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—POMC—osteoporosis	4.65e-06	0.00121	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ACP5—osteoporosis	4.57e-06	0.00119	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.51e-06	0.00117	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PKM—osteoporosis	4.39e-06	0.00114	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—FDPS—osteoporosis	4.39e-06	0.00114	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—IDH2—osteoporosis	4.35e-06	0.00113	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—TPI1—osteoporosis	4.25e-06	0.0011	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GPD2—osteoporosis	4.16e-06	0.00108	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PGLS—osteoporosis	4.16e-06	0.00108	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP27A1—osteoporosis	4.09e-06	0.00106	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	4.01e-06	0.00104	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	4e-06	0.00104	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—P4HB—osteoporosis	3.99e-06	0.00104	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ACP5—osteoporosis	3.98e-06	0.00103	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GAPDH—osteoporosis	3.92e-06	0.00102	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—RAP1A—osteoporosis	3.82e-06	0.00099	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PNP—osteoporosis	3.8e-06	0.000987	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ATIC—osteoporosis	3.8e-06	0.000987	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.75e-06	0.000973	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	3.74e-06	0.00097	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—TPI1—osteoporosis	3.7e-06	0.00096	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—P4HB—osteoporosis	3.48e-06	0.000903	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GAPDH—osteoporosis	3.41e-06	0.000886	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.33e-06	0.000864	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—RAP1A—osteoporosis	3.33e-06	0.000863	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CA2—osteoporosis	3.24e-06	0.000839	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—OXCT1—osteoporosis	3.24e-06	0.000839	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—MGLL—osteoporosis	3.15e-06	0.000818	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ENO1—osteoporosis	3.09e-06	0.000801	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PSMA5—osteoporosis	3.04e-06	0.000789	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PSMA2—osteoporosis	3.04e-06	0.000789	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ENO1—osteoporosis	2.69e-06	0.000698	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—IDH2—osteoporosis	2.68e-06	0.000696	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PSMA2—osteoporosis	2.65e-06	0.000687	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PSMA5—osteoporosis	2.65e-06	0.000687	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.52e-06	0.000654	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP19A1—osteoporosis	2.47e-06	0.00064	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ACP5—osteoporosis	2.45e-06	0.000636	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—TPI1—osteoporosis	2.28e-06	0.000591	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP19A1—osteoporosis	2.15e-06	0.000558	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—P4HB—osteoporosis	2.14e-06	0.000556	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GAPDH—osteoporosis	2.1e-06	0.000546	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—RAP1A—osteoporosis	2.05e-06	0.000532	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ADCY5—osteoporosis	2.02e-06	0.000523	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GPX1—osteoporosis	2.01e-06	0.000521	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—MTHFR—osteoporosis	1.85e-06	0.000481	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ADCY5—osteoporosis	1.76e-06	0.000456	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GPX1—osteoporosis	1.75e-06	0.000454	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ENO1—osteoporosis	1.66e-06	0.00043	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PSMA2—osteoporosis	1.63e-06	0.000423	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PSMA5—osteoporosis	1.63e-06	0.000423	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—MTHFR—osteoporosis	1.61e-06	0.000419	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—POMC—osteoporosis	1.48e-06	0.000385	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.32e-06	0.000344	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—POMC—osteoporosis	1.29e-06	0.000335	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ADCY5—osteoporosis	1.08e-06	0.000281	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GPX1—osteoporosis	1.08e-06	0.00028	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—MTHFR—osteoporosis	9.95e-07	0.000258	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—POMC—osteoporosis	7.96e-07	0.000206	CbGpPWpGaD
